Jan 20, 2022New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast CancerJERUSALEM, Jan 20, 2022 – Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha...
Jan 10, 2022Results of First US Clinical Trial of Alpha DaRT™Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response...
Jan 3, 2022Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck CancerJERUSALEM, Dec. 31, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Jan 2, 2022Alpha DaRT Investigator Meeting in Las VegasComing Up Soon - Alpha DaRT Investigator Meeting in Las Vegas Alpha Tau is pleased to announce that the Alpha DaRT Investigator Meeting,...